Background illustration for clinical trials search

High Blood Pressure Clinical Trials

Browse 1,116 High Blood Pressure clinical trials enrolling across the United States and Canada. 95 people applied to High Blood Pressure studies last month. Search by city or state to find one near you.

Filter
1

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Boston MA, Stony Brook NY, New York NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06140524

Phase2, Recruiting

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

for
Breast, Metastatic, Triple Negative, Cancer,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18 - 70+

Code: NCT04333706

Phase1, Phase2, Recruiting

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

for
Head and Neck Cancer,
Location: Winston-Salem NC, Charlotte NC, Milwaukee WI
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06607406

Recruiting

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

for
Sickle Cell Disease
Location: Chicago IL
Sponsor: EpiDestiny, Inc.

Sex: All

Age: 18+

Code: NCT04055818

Phase1, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: South Weymouth MA, Danvers MA, Waltham MA, Boston MA,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

for
Refractory and/or Relapsed Metastatic Solid Tumors
Location: Valhalla NY, The Bronx NY, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 1 - 50

Code: NCT01804634

Phase2, Recruiting

A Novel Obesity Prevention Program for High-Risk Infants in Primary Care

for
Obesity, Obesity, Childhood, Weight Gain,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT06028113

Phase2, Recruiting

Definitive Radiation for High-Risk Spine Metastases

for
Metastatic Cancer, Metastatic Lung Cancer,
Location: Stony Brook NY
Sponsor: Stony Brook University

Sex: All

Age: 18+

Code: NCT06165419

Phase2, Recruiting

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

for
Melanoma
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06365619

Phase2, Recruiting

Efficacy & Safety for LN144 with Pembrolizumab with High Risk Stage IIIb-dResectable Melanoma

for
Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IIID Melanoma
Location: Cleveland OH
Sponsor: James Isaacs, MD

Sex: All

Age: 18+

Code: NCT06190249

Phase1, Recruiting

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

for
Prostate Cancer
Location: Portland OR
Sponsor: Mark Garzotto, MD

Sex: Male

Age: 18+

Code: NCT03753243

Phase2, Recruiting

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

for
Thyroid Gland Follicular Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06440850

Phase2, Recruiting

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

for
Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma,
Location: New York NY, Salt Lake City UT, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05861050

Phase1, Phase2, Recruiting

Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

for
Multiple Myeloma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT05776979

Phase2, Recruiting

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

for
Bladder Cancer, Bladder Cancer Recurrent, Neoplasm Recurrence,
Location: Kingston, Toronto, Vancouver
Sponsor: Verity Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT05037279

Phase3, Recruiting

Feasibility of an In-home Standing and Walking Intervention for Infants With and at High Risk of Cerebral Palsy

for
Cerebral Palsy
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 0 - 2

Code: NCT05781438

Recruiting

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Saint John, Montreal, Ottawa, Winnipeg, Vancouver
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT05371808

Recruiting

Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial

for
Smoldering Multiple Myeloma
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06212323

Recruiting

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

for
Rhabdomyosarcoma
Location: Memphis TN, Palo Alto CA
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 22

Code: NCT06023641

Phase2, Recruiting

Implementing a Brief Suicide Intervention for High Risk Youth With Front-Line Juvenile Justice Staff

for
Suicide and Self Harm
Location: Providence RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 12 - 17

Code: NCT02981420

Recruiting